Literature DB >> 21943458

Do sonographic and cytological features predict malignancy in cytologically indeterminate thyroid nodules?

S Dutta1, M A Thaha, D M Smith.   

Abstract

INTRODUCTION: The current algorithm for managing patients with indeterminate (Thy3) thyroid cytology is a thyroid lobectomy followed by a completion thyroidectomy depending on histology. We investigated whether sonographic and or cytological features in addition to clinical characteristics would predict the potential for malignancy in a cohort of patients with thyroid nodules of indeterminate cytology.
METHODS: Perusing a clinical database of all patients undergoing ultrasonography guided fine needle aspiration (FNA) of thyroid nodules, we identified all Thy3 lesions. The demographic, ultrasonography and cytological details of benign and malignant groups were compared by t-test, chi-square test and, when appropriate, Fisher's exact test. Association between studied characteristics and malignancy was tested by binary logistic regression using single input. A p-value of <0.05 was considered significant.
RESULTS: During the retrospective study period of January 2003 to July 2010, a total of 1,019 patients underwent FNA, of which 69 (6.8%) were classed as Thy3. Of these, 59 underwent surgical treatment and the histological outcomes were grouped as benign (n=42, 71.2%) and malignant (n=17, 28.8%). These groups were analysed for the predictive variables. Age, sex and sonological characters were similar in the two groups (p>0.05). The two microcalcifications observed were both in the malignant group. Among all the variables assessed, only the absence of normal follicular cells was associated with malignant nodules (univariate analysis, p=0.034).
CONCLUSIONS: Malignancy was more common in Thy3 patients with an absence of normal follicular cells and such patients may therefore warrant a total thyroidectomy.

Entities:  

Mesh:

Year:  2011        PMID: 21943458      PMCID: PMC3365452          DOI: 10.1308/003588411X580160

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  22 in total

Review 1.  Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours.

Authors:  Bryan R Haugen; Whitney W Woodmansee; Michael T McDermott
Journal:  Clin Endocrinol (Oxf)       Date:  2002-03       Impact factor: 3.478

2.  Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions.

Authors:  Marille E Herrmann; Virginia A LiVolsi; Theresa L Pasha; Shelley A Roberts; Eva M Wojcik; Zubair W Baloch
Journal:  Arch Pathol Lab Med       Date:  2002-06       Impact factor: 5.534

Review 3.  Fine-needle aspiration biopsy of the thyroid: an appraisal.

Authors:  H Gharib; J R Goellner
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391

4.  Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.

Authors:  Richard E Goldstein; James L Netterville; Brian Burkey; Joyce E Johnson
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

5.  Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues.

Authors:  C De Micco; J Ruf; M A Chrestian; N Gros; J F Henry; P Carayon
Journal:  Cancer       Date:  1991-06-15       Impact factor: 6.860

6.  Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients.

Authors:  W Raber; K Kaserer; B Niederle; H Vierhapper
Journal:  Thyroid       Date:  2000-08       Impact factor: 6.568

7.  A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples.

Authors:  Nia D Banks; Jeanne Kowalski; Hua-Ling Tsai; Helina Somervell; Ralph Tufano; Alan P B Dackiw; Michael R Marohn; Douglas P Clark; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

8.  Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients.

Authors:  Guido M Sclabas; Gregg A Staerkel; Suzanne E Shapiro; Bruno D Fornage; Steven I Sherman; Rena Vassillopoulou-Sellin; Jeffrey E Lee; Douglas B Evans
Journal:  Am J Surg       Date:  2003-12       Impact factor: 2.565

9.  Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings.

Authors:  H Gharib; J R Goellner; A R Zinsmeister; C S Grant; J A Van Heerden
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

10.  Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity.

Authors:  A Belfiore; G L La Rosa; G A La Porta; D Giuffrida; G Milazzo; L Lupo; C Regalbuto; R Vigneri
Journal:  Am J Med       Date:  1992-10       Impact factor: 4.965

View more
  4 in total

1.  Radiologic and clinical predictors of malignancy in the follicular lesion of undetermined significance of the thyroid.

Authors:  Ryan Carr; Berrin Ustun; David Chhieng; Kevin Schofield; Constantine Theoharis; Lynwood Hammers; Adebowale J Adeniran
Journal:  Endocr Pathol       Date:  2013-06       Impact factor: 3.943

2.  Ultrasound predictors of malignancy in indeterminate thyroid nodules.

Authors:  M-L Matthey-Gie; S M Walsh; A C O'Neill; A Lowery; D Evoy; D Gibbons; R S Prichard; S Skehan; E W McDermott
Journal:  Ir J Med Sci       Date:  2014-01-09       Impact factor: 1.568

3.  GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE.

Authors:  David F Schneider; Linda M Cherney Stafford; Nicole Brys; Caprice C Greenberg; Courtney J Balentine; Dawn M Elfenbein; Susan C Pitt
Journal:  Endocr Pract       Date:  2017-01-17       Impact factor: 3.443

4.  Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?

Authors:  Pietro Giorgio Calò; Fabio Medas; Rosa Santa Cruz; Francesco Podda; Enrico Erdas; Giuseppe Pisano; Angelo Nicolosi
Journal:  BMC Surg       Date:  2014-03-06       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.